113 related articles for article (PubMed ID: 34046792)
1. Comparative Characterization of Lymphoid Infiltration in Different Molecular-Biological Subtypes of Invasive Breast Cancer.
Erofeeva LM; Mnikhovich MV
Bull Exp Biol Med; 2021 May; 171(1):62-67. PubMed ID: 34046792
[TBL] [Abstract][Full Text] [Related]
2. Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers.
Seow DYB; Yeong JPS; Lim JX; Chia N; Lim JCT; Ong CCH; Tan PH; Iqbal J
Breast Cancer Res Treat; 2020 Apr; 180(2):369-377. PubMed ID: 32034580
[TBL] [Abstract][Full Text] [Related]
3. Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced
Garaud S; Zayakin P; Buisseret L; Rulle U; Silina K; de Wind A; Van den Eyden G; Larsimont D; Willard-Gallo K; Linē A
Front Immunol; 2018; 9():2660. PubMed ID: 30515157
[TBL] [Abstract][Full Text] [Related]
4. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; Okoń K
Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433
[TBL] [Abstract][Full Text] [Related]
5. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.
Cimino-Mathews A; Ye X; Meeker A; Argani P; Emens LA
Hum Pathol; 2013 Oct; 44(10):2055-63. PubMed ID: 23701942
[TBL] [Abstract][Full Text] [Related]
6. B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer.
Sakimura C; Tanaka H; Okuno T; Hiramatsu S; Muguruma K; Hirakawa K; Wanibuchi H; Ohira M
J Surg Res; 2017 Jul; 215():74-82. PubMed ID: 28688665
[TBL] [Abstract][Full Text] [Related]
7. CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.
Liu S; Lachapelle J; Leung S; Gao D; Foulkes WD; Nielsen TO
Breast Cancer Res; 2012 Mar; 14(2):R48. PubMed ID: 22420471
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes are associated with β-catenin overexpression in breast cancer.
Ma X; Zhao X; Yan W; Yang J; Zhao X; Zhang H; Hui Y; Zhang S
Cancer Biomark; 2018 Feb; 21(3):639-650. PubMed ID: 29286921
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.
Althobiti M; Aleskandarany MA; Joseph C; Toss M; Mongan N; Diez-Rodriguez M; Nolan CC; Ashankyty I; Ellis IO; Green AR; Rakha EA
Histopathology; 2018 Dec; 73(6):887-896. PubMed ID: 29947077
[TBL] [Abstract][Full Text] [Related]
10. Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya.
Sawe RT; Mining SK; Ofulla AV; Patel K; Guyah B; Chumba D; Prosperi JR; Kerper M; Shi Z; Sandoval-Cooper M; Taylor K; Badve S; Stack MS; Littlepage LE
Trop Med Health; 2017; 45():19. PubMed ID: 28794686
[TBL] [Abstract][Full Text] [Related]
11. Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer.
Miyan M; Schmidt-Mende J; Kiessling R; Poschke I; de Boniface J
J Transl Med; 2016 Jul; 14(1):227. PubMed ID: 27473163
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.
Nederlof I; De Bortoli D; Bareche Y; Nguyen B; de Maaker M; Hooijer GKJ; Buisseret L; Kok M; Smid M; Van den Eynden GGGM; Brinkman AB; Hudecek J; Koster J; Sotiriou C; Larsimont D; Martens JWM; van de Vijver MJ; Horlings HM; Salgado R; Biganzoli E; Desmedt C
Breast Cancer Res; 2019 Dec; 21(1):151. PubMed ID: 31878981
[TBL] [Abstract][Full Text] [Related]
14. Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer.
Li YQ; Liu FF; Zhang XM; Guo XJ; Ren MJ; Fu L
PLoS One; 2013; 8(10):e76379. PubMed ID: 24124553
[TBL] [Abstract][Full Text] [Related]
15. The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study.
Ben-Hur H; Cohen O; Schneider D; Gurevich P; Halperin R; Bala U; Mozes M; Zusman I
Anticancer Res; 2002; 22(2B):1231-8. PubMed ID: 12168931
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer.
Kroeger DR; Milne K; Nelson BH
Clin Cancer Res; 2016 Jun; 22(12):3005-15. PubMed ID: 26763251
[TBL] [Abstract][Full Text] [Related]
17. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.
Martinet L; Garrido I; Filleron T; Le Guellec S; Bellard E; Fournie JJ; Rochaix P; Girard JP
Cancer Res; 2011 Sep; 71(17):5678-87. PubMed ID: 21846823
[TBL] [Abstract][Full Text] [Related]
18. Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.
Garaud S; Buisseret L; Solinas C; Gu-Trantien C; de Wind A; Van den Eynden G; Naveaux C; Lodewyckx JN; Boisson A; Duvillier H; Craciun L; Ameye L; Veys I; Paesmans M; Larsimont D; Piccart-Gebhart M; Willard-Gallo K
JCI Insight; 2019 Aug; 5(18):. PubMed ID: 31408436
[TBL] [Abstract][Full Text] [Related]
19. Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer.
König L; Mairinger FD; Hoffmann O; Bittner AK; Schmid KW; Kimmig R; Kasimir-Bauer S; Bankfalvi A
BMC Cancer; 2019 Feb; 19(1):120. PubMed ID: 30717704
[TBL] [Abstract][Full Text] [Related]
20. Tumour-Infiltrating Inflammatory Cells in Early Breast Cancer: An Underrated Prognostic and Predictive Factor?
Schnellhardt S; Erber R; Büttner-Herold M; Rosahl MC; Ott OJ; Strnad V; Beckmann MW; King L; Hartmann A; Fietkau R; Distel L
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
